NBRV Stock Forecast – 2022, 2023, 2024, 2025, 2030

Nabriva Therapeutics Shares have recently been hammered by excessive selling pressure. While the Nabriva Therapeutics Shares have dropped 37.6 percent in the last month, there is still a hope at the end since it is now in overbought area, and Wall Street’s NBRV Stock Forecast experts the Nabriva Therapeutics to announce greater results than they expected previously.

Nabriva Therapeutics Stock Price Today

Currently, the Nabriva Therapeutics Stock Price is 0.59 USD, −0.021 (3.62%) today.

14 Days Historical Nabriva Therapeutics Stock Price Data

Historical Nabriva Therapeutics PLC – ADR Shares’ Price data:

• Market Cap of Nabriva Therapeutics (Previous Close): 33.46 M
• Price in USD (Previous Close): 0.591
• NBRV Stock Price Volume (Previous Close): 281,922
• Nabriva Therapeutics PLC – ADR Shares’ Price in USD (Last): 0.590
• 52 Week Change of NBRV Stock Price: -2.0937
• NBRV Stock Price’s 90-Day Moving Average: 0.911
• Beta: 1.2270511059136
• 52-week High Nabriva Therapeutics Price: 3.49
• 52-week Low Nabriva Therapeutics Price: 0.519
• 50 Day Moving Average of Nabriva Therapeutics PLC – ADR Shares’ Price: 0.7397
• 200 Day Moving Average of Nabriva Therapeutics Stock: 1.06

What Does Nabriva Therapeutics Do?

Nabriva Therapeutics PLC – ADR is a biopharmaceutical business that develops and commercializes innovative anti-infective drugs to treat viral illness. XENLETA, a semi-synthetic pleuromutilin antimicrobial for the therapy of community-acquired bacterial pneumonia, and SIVEXTRO, an oxazolidinone-class antiseptic for the treatment of severe microbial skin and skin structure illness, are among the Nabriva Therapeutics PLC – ADR’s products. Nabriva Therapeutics PLC – ADR also creates XENLETA, which is currently in Phase I clinical studies for the treatment of severe infections, sexually transmitted diseases, immune disorders, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint diseases.

Furthermore, Nabriva Therapeutics is developing CONTEPO, an epoxide antibiotic for the treatment of complex bladder infections and is now in a Stage I medical study for peri-operative prophylaxis. Previously known as Nabriva Therapeutics Forschungs GmbH, the firm changed its name to Nabriva Therapeutics PLC – ADR in 2007. Nabriva Therapeutics PLC – ADR was founded in 2005 and is based in Dublin, Ireland.

Is NBRV Stock a Good Buy?

Northland Securities is bullish on NBRV Stock and assigned it a “Outperform” rating on March 12, 2021. The Nabriva Therapeutics Stock Price Prediction has been reduced from $9.00 to $6.00.

Nabriva Therapeutics Stock Prediction News

The intense selling of Nabriva Therapeutics Stock looks to be coming to an end, as shown by its RSI reading of 25.01. As a result, Nabriva Therapeutics Stock’s trend may soon reverse in order to re-establish the original supply-and-demand balance.

The RSI number is not the sole indicator of a probable stock reversal in the near term. Fundamentally, there has been broad consensus among sell-side experts monitoring the firm to raise profit expectations for the current fiscal year. The average EPS estimate for Nabriva Therapeutics Stock has risen 0.9 percent in the last 30 days. In addition, an increasing trend in earnings estimate revisions typically correlates into price gain in the short run.

Furthermore, Nabriva Therapeutics Shares presently have a Zacks Rate #2 (Buy), putting it in the top 20% of the over than 4,000 companies that ranked based on trends in profit estimate adjustments and EPS surprises. It is a more solid sign of the stock’s possible near-term recovery.

NBRV Stock Forecast

NBRV Stock Forecast for the next days

NBRV Stock Forecast data:

• 52 Week High NBRV Stock Forecast Price: 1.712
• 52 Week Low NBRV Stock Forecast Price: 0.00141
• 45-Day Moving Average (Based on NBRV Stock Forecast data): 1.049
• 90-Day Moving Average (Based on NBRV Stock Forecast data): 323
• The price of Nabriva Therapeutics PLC – ADR Shares is 0.590 USD today.
• According to NBRV Stock Forecast 2022, 2023, 2024, 2025, 2030, the future NBRV Stock Price can decrease from 0.590 USD to 0.572 USD. The change of NBRV Stock Forecast Price will be -3.0764%.

Below you will find the Nabriva Therapeutics Stock Price Predictions for next years.